Author [ Title(Asc)] Type Year
Filters: Author is Zhang, Xiao-Hui  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Wang, Y.-T., Kong, Y., Song, Y., Han, W., Zhang, Y.-Y., Zhang, X.-H., Chang, Y.-J., Jiang, Z.-F., and Huang, X.-J. (2016). Increased type 1 immune response in the bone marrow immune microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Kong, Y., Song, Y., Hu, Y., Shi, M.-M., Wang, Y.-T., Wang, Y., Zhang, X.-H., Xu, L.-P., Liu, K.-Y., Deng, H.-K., et al. (2016). Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.Oncotarget.
Wang, X.-L., Han, W., Zhao, P., Liu, X., Wang, J.-Z., Wang, F.-R., Yan, C.-H., Zhang, Y.-Y., Mo, X.-D., Wang, Y., et al. (2019). Incidence, Risk Factors, Outcomes and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant.
Yan, C.-H., Wang, Y., Mo, X.-D., Sun, Y.-Q., Wang, F.-R., Fu, H.-X., Chen, Y., Han, T.-T., Kong, J., Cheng, Y.-F., et al. (2018). Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.Clin Infect Dis67, S162-S173.
Liu, J., Gao, H., Xu, L.-P., Mo, X.-D., Liu, R., Liang, S., Wu, N., Wang, M., Wang, Z., Chang, Y.-J., et al. (2020). Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2 T cells activities after hematopoietic transplantation for blood malignancies.J Immunother Cancer8.
Zeng, Q.-Z., Zhang, Y.-Y., Wu, Y.-J., Zhang, Z.-Y., Zhang, J.-N., Fu, H.-X., Wang, J.-Z., Wang, F.-R., Yan, C.-H., Mo, X.-D., et al. (2020). Frequency, risk factors and outcome of active tuberculosis following allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Zhang, Y.-Y., Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., et al. (2019). FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.Bone Marrow Transplant.
Zhao, X.-Y., Pei, X.-Y., Chang, Y.-J., Yu, X.-X., Xu, L.-P., Wang, Y., Zhang, X.-H., Liu, K.-Y., and Huang, X.-J. (2019). First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation.Clin Infect Dis.
Chen, Y., Huang, X.-J., Wang, Y., Liu, K.-Y., Chen, H., Chen, Y.-H., Zhang, X.-H., Wang, F.-R., Han, W., Wang, J.-Z., et al. (2015). Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors.Transfusion.
Guo, Z.-P., Wang, T., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, X.-J., and Chang, Y.-J. (2016). Factors affecting the CD34(+) cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor.Transfus Apher Sci.